Harness The Real Potential & Power Of AI & New Technologies To Maximise HCP Engagement, Patient Results & Commercial Advancement With

AI-Literate, Customer-Focused & Data-Driven Digital Pharma Marketing Strategies

Grand Ballroom, Grand Connaught Rooms London, 28th January 2026

Programme – 28th January 2026

08.15 Registration & Informal Networking

OPENING REMARKS

09.00 GIC Welcome & Morning Co-Chairs’ Opening Remarks

Dr Rene Rust, Head Of Corporate Communications, Almirall

Jag Singh, Global Omnichannel Lead Rare Diseases, CSL Vifor

HIGH-IMPACT DIGITAL STRATEGIES

09.10 Unify & Streamline Your Pharma Digital Strategies To Boost Engagement, Increase Effectiveness & Stand Out From The Competitive Crowd

  • In an increasingly digital-driven world, are your platforms and processes working at peak efficiency to deliver true value?
  • There is still a delicate balance to be struck between digital and face-to-face interactions – how can you keep the two working in harmony? What approach provides the greatest benefit to the greatest number of patients?
  • From 2026 and beyond, scan the digital horizon to assess what is in the pipeline, and its potential impact on the pharma sector
  • Utilise the most effective metrics to demonstrate your digital success, securing senior buy-in and external engagement

Sara Tea Di Niro, Marketing Specialist, Teva

AI IN ACTION: BUILDING PRACTICAL, TRUSTED & SCALABLE SOLUTIONS IN PHARMA

09.30 Unleashing AI’s Potential Isn’t About Perfection – It’s About Progress. This Session Explores How Organisations Can Apply AI In Real-World Commercial Contexts Through Clear Governance, Cross-Functional Experimentation & A Strong Focus On Trust, Value & Scalability

  • Establishing the foundations for responsible AI: governance, transparency, and alignment with business goals
  • Practical examples of AI initiatives that enhance engagement, streamline operations, and unlock insights, while keeping humans in the loop
  • Navigating ambiguity: how to move from pilot to progress by engaging teams, learning from failure, and scaling what works
  • Addressing ethical, compliance, and trust considerations to ensure AI supports – not replaces – human judgment and medical responsibility

Margarida Batista, Omnichannel Operations Lead for UKINOR, Grünenthal Group

OPTIMISED HCP ENGAGEMENT

PANEL Q&A

09.50 Capture HCPs’ Valuable Time & Attention By Addressing Fundamental Needs Head-On & Delivering Boosted Engagement Every Time

  • With an ever-evolving relationship between HCPs and the pharma sector, what is the key to successful HCP engagement in 2026 and beyond?
  • Assess and compare the merits of different channel strategies to identify the best ways to truly get through to HCPs
  • Refresh your content and comms to put your company’s best foot forward and drive towards effective patient outcomes
  • Incorporate data-driven personalisation to create unmissable content that truly speaks to HCPs’ key priorities

Craig Adkins, Head of Data, Digital & Technology, Europe & Canada, Takeda

Kiren Kaur Dulai, Senior Global Manager Omnichannel Enablement, Mundipharma

Katerina Zampeli, Senior Product Manager Diabetes & OCE, Novo Nordisk

Jag Singh, Global Omnichannel Lead Rare Diseases, CSL Vifor

Becki Morison, EVP, Global Product Strategy & International Operations, LEO Pharma

Konstantin Ivanov, Commercial Excellence & Operations Head (Hungary, Bulgaria, Romania, Greece), Astellas Pharma

Anastasia Roshchina, CEE Marketing Director For Buscopan No-Spa, Opella

10.20 Bonus Session; Reserved For Exclusive Conference Partner

10.50 Morning Refreshment Break & Informal Networking

TRANSLATE DATA INTO ACTIONABLE INSIGHTS

11.20 Deep-Dive Into Data & Maximise This Invaluable Resource With Forward-Thinking Collection, Analysis, Personalisation & Compliance Strategies

  • How can tech advances help in sifting through complex data to highlight what’s most relevant and what can be ignored? How can you ensure metrics are based in value, not vanity?
  • Unify data across multiple channels, platforms and silos to generate and showcase meaningful results

Adam Thornton, Associate Director Omnichannel Strategy, Bristol Myers Squibb

PRACTICAL AI INNOVATIONS: POWERFUL STRATEGIES WITH PROVEN VALUE

PANEL Q&A

11.40 The Future Is Now! Practical Approaches On Applying AI To Enhance Consumer Experience, Reduce Workloads & Drive Business Efficiencies Without Losing The Human Touch

  • How can pharma continue to move away from theory and put AI into practice? From content creation to patient interaction, what actionable, results-driven approaches can be implemented today?
  • Debate the ethics of AI and how your results can be validated: assess the limits of how far AI can be utilised while still remaining compliant, safe and trustworthy
  • With patients able to access ChatGPT and other AI tools for themselves, how can pharma companies safeguard consumers, encourage the use of proper medical channels, and mitigate the potential spread of misinformation?
  • Crunch the numbers! With huge volumes of available data, and time a precious resource, utilise AI as a tool to filter and find the most relevant data points, mitigating labour-intensive processes and speeding up deliverable results

Richard Jones, Senior Director, Enterprise Architecture Commercial Practice, Pfizer

Marta Bukala, Head of Digital UK&I, Bayer Consumer Health

Ruben Bueno, Customer Engagement & Business Excellence Senior Director, Novo Nordisk

SOCIAL MEDIA CHANNELS & CONTENT

12.10 Revitalise Social Media Strategies & Optimise Engagement By Delivering The Right Content On The Right Channels At The Right Time

  • With attitudes and approaches to social media evolving faster than ever, how can pharma best utilise this asset in 2026 and beyond?
  • Harness customer data insights to learn what consumers are truly responding to across content, channels and messaging
  • Inject vital new spark into your social media content to boost engagement and set yourself apart from the competition
  • Work hand-in-hand with regulatory teams to maximise the cut-through impact of social media content while remaining compliant and prioritising ethics

Kayhan Binazir, Global Medical Director, Respiratory Pathogens, GSK

INNOVATIVE DIGITAL TRANSFORMATION

12.30 Foster A Company-Wide Mindset That Embraces Digital Transformation To Drive Real Results, Without Losing Sight Of The Key Fundamentals

  • Embrace the change! Promote digital literacy and a forward-looking mindset among senior leadership and employees alike
  • Highlight critical successes to demonstrate a results-first approach and inspire company-wide digital innovation and adoption
  • Keep practical actionability in mind and ensure that key marketing and comms fundamentals don’t get lost in the transition to digital
  • Leverage the latest technologies to upscale digital processes while keeping costs and workloads manageable

Frédéric Baffou, Head of Multichannel & Digital Marketing, Neuromodulation, International, Medtronic

12.50 Bonus Session; Reserved For Exclusive Conference Partner

13.05 Lunch & Informal Networking For Speakers, Delegates & Partners

13.30 Informal Breakout Discussions

A) Employee Engagement

Suzi Archer, People Engagement Director, Norgine

B) How To Make Omnichannel Feel Personal At Scale

How Are You Balancing Automation & Personalisation In Your Omnichannel Strategy?

Antonio Cravino, Customer Engagement Lead, Sanofi

C) Personalisation

D) Geopolitics

E) Medical Devices

F) Cyber Security

OPENING REMARKS

14.05 Afternoon Co-Chairs’ Opening Remarks

Kishan Rees, Senior Director Video & Digital Content Strategy, Bayer

Karen Borrer, Head Of Communications, UK & Ireland, UCB

14.10 Bonus Session; Reserved For Exclusive Conference Partner

REGULATION, LEGAL & COMPLIANCE: FIRST-HAND, CRITICAL INSIGHTS

PANEL Q&A

14.25 Reinforce Regulatory Understanding & Compliant Mindsets Across Data, AI & More, To Drive Reputational Strength & Well-Earned Trust

  • With regulations shaping and guiding the evolution of digital pharma, what is next in the pipeline, and what will the immediate future of regulatory compliance look like?
  • Foster a culture of widespread communication across different countries, sectors and teams to ensure compliance requirements are always being met
  • Content creation, data privacy, the use of AI – assess the regulatory pitfalls behind modern digital practices and learn how to avoid them
  • Alter your mindset! Rather than a negative necessity, how can regulation and compliance be better positioned as a positive force to drive trust and patient safety?

Antonios Roussos, Head of E&C Global Excellence & Innovation, Astellas Pharma Inc.

Antoinette Keane, Executive Director, Head of Ethics & Compliance EUR/INT, Jazz Pharmaceuticals

Tamara Chisholm, Senior Healthcare Legal &Compliance Director, Gilead Sciences

Anastasia Troyan, Senior Director Global Compliance & Ethics, Teva

Corlia Van Der Walt, Director R&D Partnerships & Legal Compliance, AstraZeneca

MEASURING & SHOWCASING DIGITAL SUCCESS

14.55 Avoid Valueless Vanity Metrics & Focus On Your Pharma Brand’s Most Pure & Powerful Narrative Through Cutting-Edge Measurements & Metrics

  • Cut through the noise and get to the heart of the data, to see what is truly working and where the most value is being added
  • Control the narrative – what does success look like to your organisation? Are your current metrics capitalising on this, and best positioned to showcase what matters most?
  • How can company-wide data points be brought together to tell a cohesive story, securing engagement and buy-in at all levels?
  • Contrast different measurement tools and reporting strategies to find out what best broadcasts your message

PATIENT CENTRICITY & ENGAGEMENT

15.15 Keep Up With Changing Patient Behaviours To Engage Directly & Effectively With This Key Demographic & Put Patient Needs At The Heart Of Your Digital Strategies

  • The tailored method – how can you craft a patient-first approach, and how does speaking to this audience this differ from HCP engagement?
  • As patients become very more knowledgeable about their options, and with constant access to “Doctor Google”, ensure that your outreach strategies speak to modern-day concerns
  • Take advantage of tech advances and the power of AI to create relevant and personalised content that lets patients know they are seen and heard
  • Maintain trust and reputational strength by positioning transparency, ethics and regulatory compliance foremost in your patient-centric mindset

Simeón Baker, Director of Engagement & External Affairs, Genomics England

15.35 Bonus Session; Reserved For Exclusive Conference Partner

16.05 Afternoon Refreshment Break & Informal Networking

OMNICHANNEL SUCCESS IN 2026 & BEYOND

PANEL Q&A

16.35 Get To Know Your Audience! Revolutionise Your Omnichannel Strategy By Assessing The Effectiveness Of All Channels & Platforms To Truly Speak To Your Target Consumers

  • Generate brand loyalty and trust by co-ordinating a coherent, unified omnichannel strategy that delivers at every touchpoint
  • Incorporate the latest data insights to remove friction and identify weak spots in your customs journeys, as well as adding crucial personalisation to make your content truly memorable
  • Put the user first! Ensure your omnichannel approach doesn’t just work behind the scenes, but prioritises customer experience
  • One size doesn’t fit all – tailor your content across all apps and platforms to deliver timely and concise messaging without bombarding your audiences

Ryan Twiname, Head of Global Digital Engagement Strategy, LEO Pharma

Pablo Regueras Escudero, Commercial Co-Lead Oncology/Oncohematology Unit Marketing, Astellas Pharma

Trina Di Giusto, Global Business Solutions Lead, Roche

Lucillia Abbud, Global Campaign & Content Data Sr. Manager, Almirall

Özlem Önal Baran, Marketing Director, Allergan Aesthetics, AbbVie

Gozde Ipek Arslan, Digital & Customer Engagement Director, BAMECA & BAAF, Novo Nordisk

MAXIMISING DIGITAL TOUCHPOINTS

17.05 Chart An Effective Roadmap Between Digital Touchpoints To Smooth Out Consumer Journeys & Ensure That Digital Interaction Never Feels Like A Chore

  • Evaluate the full consumer experience, step by step, to create a smooth and cohesive transition across multiple digital touchpoints
  • Assess the merits of the latest technologies to enhance your customers’ digital experience without exceeding budgets
  • Embed personalisation and speed up digital journeys by using customer data in a tailored and effective way
  • Collaborate across multiple internal teams, channels and processes to join up disparate elements into a coherent and seamless customer experience

Ryan Twiname, Head of Global Digital Engagement Strategy, LEO Pharma

17.25 Afternoon Co-Chairs’ Closing Remarks & Close Of Conference

Kishan Rees, Senior Director Video & Digital Content Strategy, Bayer

Karen Borrer, Head Of Communications, UK & Ireland, UCB